Ownership history in Walleye Capital LLC · 33 quarters on record
This page tracks every 13F SEC filing in which Walleye Capital LLC reported a position in VIRIDIAN THERAPEUTICS INC (VRDN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 60,842 | +60,642 | +30321.0% | 0.01% | $1.9M | $31.12 |
| 2025 Q4 | UNCHANGED | 200 | — | 0% | 0.00% | $6K | $31.12 |
| 2025 Q3 | UNCHANGED | 200 | — | 0% | 0.00% | $4K | $21.58 |
| 2025 Q3 | REDUCED | 200 | -50,443 | -99.6% | 0.00% | $4K | $21.58 |
| 2025 Q3 | REDUCED | 50,643 | -13,913 | -21.6% | 0.00% | $1.1M | $21.58 |
| 2025 Q2 | ADDED | 64,556 | +56,456 | +697.0% | 0.00% | $902K | $13.98 |
| 2025 Q1 | REDUCED | 8,100 | -95,917 | -92.2% | 0.00% | $109K | $13.48 |
| 2025 Q1 | ADDED | 104,017 | +96,517 | +1286.9% | 0.01% | $1.4M | $13.48 |
| 2024 Q4 | REDUCED | 7,500 | -474,139 | -98.4% | 0.00% | $144K | $19.17 |
| 2024 Q4 | REDUCED | 481,639 | -78,368 | -14.0% | 0.02% | $9.2M | $19.17 |
As of 2025 Q4 — sorted by position size